Andrew Bellinger

All filings by Andrew Bellinger on record concern Verve Therapeutics, Inc. We count 14 filings; the first trade dates from 21 June 2021 and the latest from 14 December 2022.

In open-market terms, that means 1 purchase worth €80k on one side and 6 sales worth €2.6M on the other. On balance, insiders were net sellers of €2.5M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 7 option exercises. In 2022 alone, the filings show no purchases and 6 sales.

Most recently, on 16 December 2022, the filings show an option exercise worth €97k in Verve Therapeutics, Inc. The most recent open-market purchase was published on 21 June 2021, 1,945 days ago. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.